Transcode Therapeutics, Inc. (RNAZ) stock

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$1.32−0.07 (-5.06%)

Close on Nov 13, 2026Market cap $1.34MP/E –Yield –

Transcode Therapeutics statistics

52 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.34M; $272.32M
Enterprise Value: -$7.05M; $146.23M

Share statisticsIndustry

Shares Outstanding: 1M; 58M
Shares Change (YoY): 247.2%; 10.8%
Shares Change (QoQ): 10.3%; 0.50%
Shares Held by Institutions: 3.31%; 56.4%

Short sellingIndustry

Short Interest: 52,014; –
Short Interest Change: -5.37%; -0.80%
Short % of Shares Outstanding: 5.14%; 6.30%
Days to Cover: 1.96; 5.15

Stock price statisticsIndustry

52-Week High: $12.60; –
52-Week Low: $1.30; –
20-Day Moving Average: $1.59; –
50-Day Moving Average: $1.67; –
200-Day Moving Average: $5.72; –
Average True Range (14): $0.16; –
Price Change (1 Week): -11.4%; -1.15%
Price Change (1 Month): -26.7%; -4.87%
Price Change (3 Months): -58.2%; -21.0%
Price Change (6 Months): -80.0%; -20.6%
Price Change (YTD): -80.7%; -23.6%
Price Change (1 Year): -85.0%; -22.4%
Price Change (3 Years): -100.0%; -29.5%
Price Change (5 Years): -100.0%; -77.9%
Average Volume (10 Days): 17,484; –
Average Volume (20 Days): 21,954; –
Average Volume (90 Days): 44,427; –
Relative Volume: 0.46; 0.70
Relative Strength Index (14): 31.9; 43.4
Volatility (1 Year): 97.9%; 80.1%
Beta (5 Years): 1.50; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -53.8%; -40.6%
Return on Capital Employed (ROCE): -31.0%; -37.9%

Financial positionIndustry

Current Ratio: 1.97; 3.30
Quick Ratio: 1.55; 2.39

EfficiencyIndustry

Profits Per Employee: -$3.57M; -$689.41K
Employee Count: 12; 74
WACC: 12.6%; 10.2%

Income statement (TTM)Industry

Operating Income: -$45.13M; -$21.37M
Net Income: -$42.83M; -$22.35M
EBITDA: -$45.10M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $8.38M; $68.68M
Net Cash (Debt): $8.38M; $17.76M
Net Cash Per Share: $8.29; $0.80
Equity (Book Value): -$27.69M; $53.89M
Book Value Per Share: -$27.38; $1.50
Tangible Book Value: -$167.74M; $27.13M
Working Capital: $5.24M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$22.61M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -3207.8%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: -2.02; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	RNAZ	S&P 500	Difference	RNAZ per year	S&P 500 per year
1 month	-21.4%	-3.0%	−18.4 pts
3 months	-62.1%	-2.8%	−59.3 pts
Year to date	-80.7%	+11.5%	−92.2 pts
1 year	-84.3%	+13.5%	−97.8 pts
3 years	-100.0%	+77.7%	−177.7 pts	-95.2%	+21.1%
5 years	-100.0%	+72.6%	−172.6 pts	-94.3%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M RNAZ shares were sold short on Oct 30, 2026, down 5.4% from the previous report. At recent volumes it would take 2.0 days to buy them back. Over the last 20 sessions, 44.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	52,014	-5.4%	26,532	2.0
Oct 15, 2026	54,968	+5.6%	40,462	1.4
Sep 30, 2026	52,062	-15.2%	68,425	1.0
Sep 15, 2026	61,403	+33.5%	33,820	1.8
Aug 31, 2026	45,978	+48.7%	122,489	1.0
Aug 14, 2026	30,910	+9.4%	20,407	1.5
Jul 31, 2026	28,252	-18.0%	15,474	1.8
Jul 15, 2026	34,446	-34.8%	41,287	1.0
Jun 30, 2026	52,823	-6.6%	20,394	2.6
Jun 15, 2026	56,527	+100.9%	230,735	1.0
May 29, 2026	28,142	-22.4%	15,089	1.9
May 15, 2026	36,265	+1.4%	8,913	4.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?